| Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia G Cardiero, M Ferrandino, IL Calcaterra, G Iannuzzo, MND Di Minno, ... Genes 15 (4), 462, 2024 | | 2024 |
| Ultrasound for the assessment of arthropathy in patients with moderate haemophilia A: A multi-centre cross-sectional study IL Calcaterra, F Valeri, E Baldacci, M Napolitano, E Zanon, G Mazzucconi, ... HAEMOPHILIA 30, 70-70, 2024 | | 2024 |
| Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies I Calcaterra, A Tufano, F Strano, P Rufolo, S Donnarumma, V Palermo, ... Journal of Thrombosis and Haemostasis, 2023 | 1 | 2023 |
| PB0989 The Efficacy and Safety of Direct Oral Anticoagulants in 50 Patients with Venous Thromboembolism and Severe Thrombophilia: A Multicenter Study P Madonna, A Guida, L Mocerino, I Calcaterra, M Amitrano, A Casoria, ... Research and Practice in Thrombosis and Haemostasis 7, 101800, 2023 | | 2023 |
| PB0453 Efficacy and Safety of Direct Oral Anticoagulants in Splanchnic Vein Thrombosis: A Pooed Analysis of Literature Studies F Strano, I Calcaterra, A Tufano, P Rufolo, S Donnarumma, V Palermo, ... Research and Practice in Thrombosis and Haemostasis 7, 101807, 2023 | | 2023 |
| PB0654 Combined Point of Care Tools Improve Treatment Adherence and Health-Related Quality of Life in Patients with Hemophilia Under Regular Prophylaxis: An Observational … M Napolitano, M Di Minno, I Calcaterra, R Marino, G Malcangi, M Mattana, ... Research and Practice in Thrombosis and Haemostasis 7, 101173, 2023 | | 2023 |
| PB0124 Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet Activating Factor and its Precursors: A Combined … I Calcaterra, A Di Minno, R Orsini, M Chiesa, V Cavalca, M Tripaldella, ... Research and Practice in Thrombosis and Haemostasis 7, 100925, 2023 | | 2023 |
| Treatment with PCSK9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet activating factor and its precursors: A combined metabolomic and … A Di Minno, IL Calcaterra, R Orsini, M Chiesa, V Cavalca, A Anesi, ... Atherosclerosis 379, S63-S64, 2023 | | 2023 |
| Volanesorsen to treat severe hypertriglyceridemia: A pooled analysis of randomized controlled trials IL Calcaterra, R Lupoli, A Di Minno, MT Pontoriero, V Palermo, ... Atherosclerosis 379, S55, 2023 | | 2023 |
| Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis F Bello, A Bettiol, E Silvestri, I Mattioli, ML Urban, A Palermo, M Mazzetti, ... Rheumatology 62 (2), 835-840, 2023 | 3 | 2023 |
| Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials I Calcaterra, R Lupoli, A Di Minno, MND Di Minno European Journal of Clinical Investigation 52 (11), e13841, 2022 | 22 | 2022 |
| An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with Evolocumab® I Calcaterra, A Di Minno, A Anesi, V Cavalca, M Tripaldella, E Tremoli, ... Atherosclerosis 355, 36, 2022 | | 2022 |
| Post-bariatric hypoglycemia is associated with endothelial dysfunction and increased oxidative stress R Lupoli, I Calcaterra, G Annunziata, G Tenore, C Rainone, L Schiavo, ... Biomedicines 10 (4), 916, 2022 | 5 | 2022 |
| Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target P Ambrosino, IL Calcaterra, M Mosella, R Formisano, SE D’Anna, ... Biomedicines 10 (4), 812, 2022 | 39 | 2022 |
| Enhanced half-life recombinant factor VIII concentrates for hemophilia A: final results from extension studies MND Di Minno, A Di Minno, I Calcaterra, E Cimino, F Dell'Aquila, ... Seminars in Thrombosis and Hemostasis 48 (02), 253-255, 2022 | 5 | 2022 |
| Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study G Iannuzzo, A Buonaiuto, I Calcaterra, M Gentile, F Forte, M Tripaldella, ... Nutrition, Metabolism and Cardiovascular Diseases 32 (3), 684-691, 2022 | 13 | 2022 |
| An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab A Anesi, A Di Minno, I Calcaterra, V Cavalca, M Tripaldella, B Porro, ... Biomedicines 9 (12), 1941, 2021 | 3 | 2021 |
| Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies F Forte, I Calcaterra, R Lupoli, RC Orsini, M Chiurazzi, M Tripaldella, ... European Journal of Preventive Cardiology 28 (18), 1980-1990, 2021 | 6 | 2021 |
| Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement MD Di Taranto, C Giacobbe, D Palma, G Iannuzzo, M Gentile, I Calcaterra, ... Clinical Genetics 100 (5), 529-541, 2021 | 14 | 2021 |
| Treatment with PCSK9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: a combined metabolomic and … A Di Minno, RC Orsini, M Chiesa, V Cavalca, I Calcaterra, M Tripaldella, ... Biomedicines 9 (8), 1073, 2021 | 9 | 2021 |
Matteo Di MinnoFederico II University在 unina.it 的电子邮件经过验证
